替普利珠单抗：它是 1 型糖尿病的里程碑，还是其他自身免疫性疾病的长期风险因素？

{"title":"替普利珠单抗：它是 1 型糖尿病的里程碑，还是其他自身免疫性疾病的长期风险因素？","authors":"Gulsum Ozen, Dario Iafusco","doi":"10.2337/cd23-0073","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"70 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Teplizumab: Is It a Milestone for Type 1 Diabetes or a Risk Factor for Other Autoimmune Diseases in the Long-Term?\",\"authors\":\"Gulsum Ozen, Dario Iafusco\",\"doi\":\"10.2337/cd23-0073\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39894,\"journal\":{\"name\":\"Clinical Diabetes\",\"volume\":\"70 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/cd23-0073\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd23-0073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}